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Abstract  18 
Increasing evidence on goat milk and their derived products health benefits beyond their 19 
nutritional value show their potential as functional foods. In this study, goat milks’ fractions were 20 
tested for their total antioxidant capacity measured by different methods (ORAC, ABTS, DPPH 21 
and FRAP), as well as the angiotensin-I-converting-enzyme inhibitory and antimicrobial (against 22 
Escherichia coli and Micrococcus luteus) activities. Different whey fractions (whey; cation 23 
exchange membrane permeate, P and retentate, R) of two fermented skimmed goat milks 24 
(ultrafiltered goat milk fermented with the classical starter bacteria or with classical starter plus 25 
the Lactobacillus plantarum C4 probiotic strain) were assessed. Additionally, P fractions were 26 
divided into two sub-fractions after passing them through a 3 kDa cut-off membrane: (a) the 27 
permeate with peptides <3 kDa (P<3); (b) and the retentate with peptides and proteins >3 kDa 28 
(P>3). No differences in biological activities were observed between the two fermented milks. 29 
However, the biological peptides present in the P<3 fraction showed the highest total antioxidant 30 
capacity (for the ORAC assay) and angiotensin-I-converting-enzyme inhibitory activities. Those 31 
present in the R fraction showed the highest total antioxidant capacity against ABTS•+ and DPPH• 32 
radicals. Some antimicrobial activity against E. coli was observed for the fermented milk with the 33 
probiotic, which could be due to some peptides released by the probiotic strain. In conclusion, 34 
small and non basic bioactive peptides could be responsible of most of angiotensin-I-converting-35 
enzyme inhibitory and antioxidant activities. These findings reinforce the potential benefits of the 36 
consumption of fermented goat milk in the prevention of cardiovascular diseases associated to 37 
oxidative stress and hypertension.  38 
 39 
Keywords: goat milk, antioxidant, antimicrobial, antihypertensive, ultrafiltration, ion exchange 40 
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Introduction 43 
Fermented milks satisfy daily nutritional requirements for several nutrients and exert different 44 
health benefits.1 Furthermore, it is an important source of many bacterial strains owing to the 45 
appropriate compatibility among some of them.2 Fermented milks contain several probiotic strains, 46 
which additionally increase the already known benefits of these dairy products. Milk fermentation 47 
by classical starter bacteria (St) (Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus 48 
salivarius subsp. thermophilus) changes milk properties and increases its digestibility by a 49 
decrease in lactose concentration and pH. This process could also release biological active peptides 50 
from their inactive forms present in the corresponding sequence of the precursor protein. The 51 
specific sequence and length of released peptides depend on two main factors: (a) the precursor 52 
protein, which is different in sequence depending on the animal specie and even on the breed;3 (b) 53 
the starter bacteria, since the proteolytic system is inherent to each bacteria strain. The healthy 54 
benefits of these bioactive peptides may be attributed to their demonstrated antimicrobial, 55 
antioxidant, antihypertensive, antithrombotic, immunomodulatory and opioid activities.4 Many of 56 
the bioactive peptides have demonstrated to have multi-functional properties. Nevertheless, their 57 
specific activity depends on the amino acid composition as well as sequence. In this sense, it is 58 
well known that anionic peptides do not affect gram-negative bacteria because of repulsive 59 
electrostatic intractions between the negatively charged outer membrane and the anionic peptides.5 60 
On the other hand, some cationic peptides have shown antimicrobial effect against gram-negative 61 
bacteria. However, not all the positively charged peptides exert antimicrobial activity and the 62 
action mechanism of milk-derived antimicrobial peptides remains uncertain.6 In any case, several 63 
peptides have been discovered with antimicrobial activity that can find industrial application.6  64 
Among the different functions of bioactive peptides, antioxidant properties are very important 65 
because high levels of reactive oxygen species (ROS) and free radicals in the organism are 66 
associated to several diseases like cancer, diabetes, cardiovascular diseases, arthritis, allergies as 67 
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well as to aging.7  In addition, ROS presence in food causes quality deterioration and shelf life 68 
reduction by lipid oxidation.3 It is known that the defense systems of organisms are often not 69 
enough to prevent oxidative damage. Some researchers have stated that antioxidant peptides 70 
present in the food system play a vital role in the maintenance of antioxidant defense systems in 71 
the organism by preventing the formation of free radicals or by scavenging free radicals and 72 
reactive oxygen species, and Cheng et al. even recommended their supplementation.7 An 73 
increasing number of food protein hydrolysates and peptides have been found to exhibit 74 
antioxidant activity, especially in peptides produced from bovine milk casein.3 In vitro 75 
measurement of antioxidant activity is key in the evaluation of the antioxidant potential of 76 
bioactive peptide-enriched preparations. Due to the complex nature of antioxidants, there is no a 77 
single technique to measure the total antioxidant capacity (TAC) of a food system. Therefore, a 78 
variety of analytical techniques are employed with this aim, which can roughly be classified into 79 
two types namely, the assays based on hydrogen atom transfer (HAT) reactions and those based 80 
on electron transfer (ET).8 Then, to study the antioxidant activity of any sample it is necessary to 81 
use at least one assay of each type in order to obtain a more complete evaluation of the TAC as the 82 
different mechanisms of antioxidant action will be taken into account;9 this is particularly 83 
important when multicomponent samples are being evaluated. 84 
Most of biologically active peptides generated from milk proteins have demonstrated an 85 
angiotensin-I-converting enzyme-inhibitory activity (ACEi).10 This effect leads to a decrease in 86 
angiotensin II (potent vasoconstrictor) and a concomitant increase in the bradykinin level, finally 87 
yielding an overall reduction in the blood pressure.11 Although the inhibitory capacity of milk 88 
derived peptides is lower than that of chemically designed drugs, their production from natural 89 
sources could represent a healthier and more natural alternative for chronic treatment, without the 90 
side-effects associated to antihypertensive drugs.11 It is known that most publications on ACEi and 91 
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antihypertensive peptides consider peptides obtained from cow milk.4 However, in recent years 92 
goat milk proteins have become an important alternative source of ACEi bioactive peptides.12  93 
Previous in vitro studies have demonstrated that the probiotic strain L. plantarum C4 has a 94 
positive influence in a range of biological functions such as, mineral bioavailability,13 modulation 95 
of the intestinal microbiota14 and protective and immunomodulatory capacity in a murine model 96 
of yerseniosis.15 Taking into consideration all previous findings, it was hipothesised here that the 97 
probiotic strain could also enhance the antioxidant, ACE-inhibitory and antimicrobial activities, 98 
in fermented goats’ milks. 99 
Only a few studies have focused on the bioactivity of fermented goat milk peptidic fractions. 100 
Therefore, the aim of the present study was the evaluation of the biological activities (antimicrobial 101 
activity against Escherichia coli and Micrococcus luteus, TAC measured by ORAC, ABTS, DPPH 102 
and FRAP methods, and ACEi-activity) of two fermented skimmed goat milks fermented with the 103 
classical starter bacteria [StFM] or with classical starter plus the Lactobacillus plantarum C4 104 
probiotic strain [St+LPFM]).  The use of the probiotic strain L. plantarum C4 on the milk protein 105 
concentrates produced by a local breed of goat for the fermentation process was investigated here 106 
for the first time in order to produce a milk product with enhanced biological activities. In addition 107 
a novel approach was followed for the physicochemical characterisation (size and charge) of the 108 
peptides in the fermented milk in relation to their bioactivities.  109 
 110 
Results and discussion 111 
Total protein analysis 112 
As stated in Table 1 a significantly higher protein concentration was observed in whey and 113 
permeate (P) fractions when compared to the retentate (R), which means a large proportion of the 114 
peptides produced by the tested fermenting strains were anionic or nonionic. Additionally, the 115 
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fractions of StFM have a higher protein concentration than St+LPFM; that may be due to 116 
differences in the fermentation process between St and L. plantarum C4, in particular pH, as a 117 
lower pH was recorded for the fermentation with the probiotic (4.25 ± 0.02) vs. StFM (4.39 ± 0.05) 118 
which could have led to more protein coagulation and less soluble protein/peptide.16  119 
 120 
Total antioxidant capacity  121 
The results obtained for TAC showed a good correlation with protein content (p<0.001; r: 122 
ORAC=0.772, ABTS=0.906 and FRAP=0.950), which could be attributed to the activity of 123 
peptides present in those fractions. In order to find which of the fractions had the most active 124 
peptides the results were also expressed as µmol Trolox equivalents mg of protein-1 (Fig. 1). The 125 
most active fractions were different to those identified when expressed as Trolox equivalents mL-126 
1, which means that not always the most active peptides were in the most active fractions.     127 
The highest TAC of the fermented milk fractions (Fig. 1) was measured by ORAC for the P<3 128 
fraction (reaching 2.927 ± 0.043 µmol Trolox equivalents mL-1 in the StFM) . However, according 129 
to the other assays, the different milk fractions did not reach 0.4 µmol Trolox equivalents mL-1 130 
(Fig. 1) for any of the fermented milks (StFM and St+LPFM). Thus, in the case of the FRAP and 131 
ABTS assays, the highest TAC was found for the whey and P fractions. Therefore these results 132 
show that fractionation by IEX did not result in increased activity as whey and P samples had 133 
similar TAC according to all methods while the retained fraction had lower activity (particularly 134 
according to ORAC and FRAP methods). On the other hand the fractionation by size 135 
(ultrafiltration) resulted in significant differences in antioxidant capacity (Fig. 1) with an important 136 
increase in activity. P<3 kDa fractionation showed higher values according to ORAC, ABTS and 137 
DPPH methods, while no significant differences were observed between these fractions in FRAP 138 
assay. 139 
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The measured TAC (by ORAC and ABTS assays) for almost all analyzed fractions was 140 
significantly higher for StFM than for St+LPFM (Fig. 1). Only the samples from St+LPFM had 141 
significantly higher antioxidant capacity in whey fraction according to DPPH assay. The variation 142 
in TAC when using the different methods could be attributed to the presence of different peptides 143 
that act by different mechanisms.  It has been demonstrated that the TAC of dairy products is 144 
mainly due to the activity of peptides. Some authors agreed that the main contribution to TAC 145 
comes from casein fractions in milk, suggesting that such effect is related to the self-oxidation of 146 
caseins’ amino-acid residues as well as their derived peptides. Additionally, they reported that this 147 
activity cannot be replaced by free amino acids since it is the primary structure of casein itself who 148 
plays a determining role.17  Among the caseins that release antioxidant peptides, β-CN could be 149 
preferably degraded by lactic acid bacteria because it is more unstructured and accessible to 150 
cleavage, and therefore hydrolyzed to a greater extent.7 On the other hand, β-LG and lactoferrin 151 
have been reported as key components for their high scavenging activity, releasing also peptides 152 
with this activity.18 The TAC of peptides has been described as remarkably dependent on factors 153 
like molecular weight, amino acid composition and sequence.19 Many authors reported that most 154 
of milk protein-derived peptides with antioxidant activity have less than 20 amino-acid 155 
residues.1,7,11  This is in agreement with our results as the P<3 fraction, with peptides of MW< 156 
3000 (up to about 20 amino-acid residues), had the highest TAC (measured by ORAC), reaching 157 
more than 1 µmol trolox equivalents mg protein-1 (Fig. 1). Nevertheless, Virtanen et al.,20 reported 158 
the contrary, supporting higher scavenging activity against the ABTS•+ radical of peptides with 159 
more than 4 kDa. However, we found that  the R fraction contained the peptides with significantly 160 
highest TAC against ABTS•+ and DPPH• radicals  (~ 0.4 µmol trolox equivalents mg protein-1; 161 
Fig. 1). These findings agree with the results reported by other researchers,21 who stated that basic 162 
peptides had greater capacity to scavenge hydroxyl radical than weak acidic or neutral ones. 163 
Few studies have indicated that the radical scavenging activity is strain-specific and that the 164 
higher proteolysis is not always associated with higher TAC.20,22 In our study no significant 165 
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differences were observed for P<3 fraction (µmol trolox equivalents mL-1) between StFM and 166 
St+LPFM, and for almost any other fraction when results were expressed as µmol trolox 167 
equivalents mg of protein-1. Therefore, the putative probiotic strain L. plantarum C4 by itself or 168 
by its interaction with St produced no increase in the antioxidant capacity of the fractions.  169 
It is known that goat milk has more β-CN than cow milk. In particular, the analyzed fermented 170 
goat milks were concentrated in caseins, therefore it was expected to obtain more β-CN derived 171 
peptides than from cow fermented milk. Notwithstanding, results were in the range of those 172 
reported for whey fractions of cow fermented milks tested against ABTS, ranging from 0.2774 to 173 
2.0356 µmol trolox equivalents mL-1.22  However, the whey fraction had higher TAC than those 174 
reported for nonfermented milks (0.489 in UHT and 1.078 µmol trolox equivalents mL-1 in 175 
pasteurized milk).23 This finding is probably related to the proteolytic activity of the fermenting 176 
strains, which were able to release the antioxidant peptides from milk proteins.24 177 
On the other hand, StFM and St+LPFM were produced only in 6 h whereas some authors 178 
reported that TAC increases with fermentation time up to 24-48 h.7,22 Some studies reported low 179 
TAC of the whey fraction, but after fractionation by HPLC, different fractions with higher TAC 180 
were obtained.22 Consequently, future research should focus on fractionating and identifying the 181 
peptides responsible of the TAC in the whey fraction.  182 
Saura-Calixto and Goñi24 reported a total antioxidant daily intake in a typical Spanish diet of 183 
3,549 µmol trolox equivalents (ABTS) and 6,014 µmol trolox equivalents (FRAP). Taking into 184 
account the whey obtained from a portion of fermented milk sample (200 g), the percentage for 185 
which this whey participate in the daily antioxidant intake is 0.75% for the ABTS and 0.50% for 186 
the FRAP methods.24 However, the total antioxidant activity of the fermented milk should be 187 
higher if we consider the precipitated fraction, with precipitated caseins and bacteria for which an 188 
antioxidant activity has also been reported elsewhere.1  189 
Finally, the TAC (Trolox equivalents mL-1) values of the fractions obtained by the different 190 
methods were significantly (p < 0.001) correlated with each other (r> 0.830 and r= 0.770 for the 191 
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ABTS-FRAP and ORAC-FRAP, respectively). DPPH was not significantly correlated with any of 192 
the other methods. However, when the TAC was expressed based on protein content a significant 193 
correlation was also found for DPPH-ABTS (r= 0.937 at  p < 0.001) and ORAC-FRAP (r= 0.807 194 
at p < 0.001). This additional significant correlation between DPPH-ABTS could be explained by 195 
considering mainly the peptides/proteins responsible for the antioxidant capacity. This is very 196 
interesting as there was very good correlation between methods testing antioxidant capacity based 197 
on the same mechanism, as DPPH and ABTS are based on both hydrogen atom transfer (HAT) 198 
and single electron transfer reactions (SET); the highest TAC was found in the retentate according 199 
to the ABTS and DPPH methods. Moreover there was also good correlation between methods 200 
based on different mechanisms FRAP (SET) and ORAC (HAT) but with biological relevance 201 
; the highest TAC was found in permeate according to the FRAP and ORAC methods. These 202 
results demonstrate that different types of antioxidants are recovered in the different fractions with 203 
differences in their antioxidant mechanism. 204 
 205 
ACEi% activity 206 
Firstly, the measured IC50 obtained for captopril was 0.023 µM, in the range reported by the 207 
manufacturer (0.021 ± 0.013 μM). This result confirms the reliability of the method used. In Fig. 208 
2a, the ACEi activities of the different fractions of fermented goat milks expressed as percentage 209 
of inhibition are shown. The whey and P<3 fractions had the highest ACEi activity (about 50%). 210 
Interestingly the R fraction did not show any activity.  211 
 212 
Given that in previous in vitro studies13-15 the fermentation by the probiotic strain L. plantarum 213 
C4 had led to a range of biological functions the ACEi activity was tested here. Nevertheless, no 214 
significant differences were found between StFM and St+LPFM for any of the analysed fractions. 215 
Therefore, adding the L. plantarum C4 probiotic strain did not significantly increase the ACEi 216 
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when compared to StFM. Gonzalez-Gonzalez et al.27 found a strain of L. plantarum able to produce 217 
a supernatant with high ACEi activity after 24 h of fermentation. Regarding the other 218 
microorganisms used,  L. bulgaricus has been reported as one of the most proteolytic 219 
microorganism as well as a great producer of ACEi peptides25; high ACEi activity (more than 220 
50%) was measured in supernatants obtained from milk fermented with 4 strains of L. bulgaricus 221 
26. As stated above for TAC, ACEi activity was significantly correlated with protein concentration 222 
(r2= 0.800; p < 0.001). When results were expressed as ACEi% mg protein-1, the permeate fractions 223 
had the highest activity and in particular the P <3 fraction (Fig. 2b). Therefore, as expected, smaller 224 
peptides had the highest ACEi (Fig. 2b). In that sense, the fractionation by size led to an increase 225 
in the activity. Interestingly charge had also an effect on activity28 as the positively charged 226 
fraction of peptides (R) had very little activity (Fig. 2b). Hence the basic peptides had much less 227 
activity than the acidic (negatively charged and noncharged) peptides. This is in accordance with 228 
the results of Welderufael et al.,28 who found that one of the fractions of the enzymatic whey 229 
hydrolysate with peptides derived from -lactoglobulin with highest ACEi and lowest IC50, 230 
contained as main peptides acidic peptides  such as IIAE with isoelectric point 4.6.  231 
ACEi% reported values for fermented milk whey are very variable depending on the strain 232 
used. For milks fermented with L. bulgaricus and S. thermophilus, most of the reported values are 233 
around the 50%, ranging from 25% to 70% of ACEi% activity11,25 . Some work was carried out 234 
with 13 strains at 3 different final pH’s and found that the maximum inhibitory activity was 51% 235 
for milk fermented with Lactococcus lactis 3906 and with final pH 4.3. However, the milk 236 
fermented with S. thermophilus did not reach the 18% of ACEi activity.29 Otte et al. demonstrated 237 
a negative correlation between pH and ACEi activity of milk fermented with two strains of L. 238 
helveticus and two species of the Lactococcus genus, reporting a range from  8 % to 50% of ACEi 239 
activity.30 However, higher values of ACEi activity were found in milk fermented with other 240 
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strains like Kumis bacteria, ranging from 10.1 to 74.3 % and up to 100% when fermented with St 241 
plus L. acidophilus L10, L. casei L26 and B. lactis B9411,31 . 242 
On the other hand, the ACEi activity has been demonstrated to be related to ionic calcium 243 
(Ca2+), since its concentration may activate or inhibit the ACE.27 We demonstrated that goat UFM 244 
was concentrated in caseins and that the ultrafiltration process changed Ca2+ distribution 245 
[percentage of Ca associated  to caseins changed from 63% in goat raw milk (RM) to 51% in goat 246 
UFM] and Ca2+ content from 135.2 ± 10 to 165.6 ± 15.1 mg/100g in goat RM and UFM, 247 
respectively. 32 Additionally, the most potent antihypertensive and ACE-inhibitory peptides are 248 
generated from caseinates and casein fractions.33 These findings could explain the high ACEi % 249 
found in our fermented goat milk samples. Moreover the fermentation with the probiotic L. 250 
plantarum did not result in increased ACEi activity. One of its strains was reported to be the best 251 
γ-amino butyric acid (GABA) synthesizer; GABA is a non-protein derived amino acid with 252 
demonstrated hypotensive effect in rats and humans.34 Future studies should focus on GABA 253 
production by the probiotic L. plantarum C4, due to its possible relationship with the hypertension 254 
control. 255 
 256 
 257 
Antimicrobial activity  258 
According to the well diffusion assay, no antimicrobial activity of the supernatants against E. 259 
coli was observed (p > 0.05). By contrast, in the whey and P fractions, E. coli grew even better 260 
than in the control assay. Nevertheless, in the spot assay for both whey and P fractions E.coli did 261 
not grow where the drop was placed, probably due to the low pH of the samples (4.33 and 4.59 for 262 
whey and P fractions, respectively). However, R fraction, with higher pH (6.97) due to the 263 
presence of cationic peptides did not show any activity against E. coli. In relation to M. luteus, we 264 
did not find any inhibition neither in the well diffusion assay nor in the spot test. On the contrary, 265 
even higher growth was found around the well of the whey fraction compared to the other fractions 266 
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where no effect was shown. Additionally, the co-culture assay was carried out to evaluate more 267 
precisely the possible inhibition of E. coli by the studied fractions. None of the fractions of the 268 
fermented milk studied showed antimicrobial activity and the pathogen grew almost as much as in 269 
the control (Fig. 3). However, after 24 h significant differences in E. coli viable bacteria among 270 
control and whey and P fractions of both fermented milks (StFM and St+LPFM), and R fraction 271 
of St+LPFM, were found. This inhibition could be due to the acidic pH of whey and P fractions 272 
(as mentioned above). However, the R fraction had a pH more similar to the control’s. So in this 273 
case, the antimicrobial activity could be due to the cationic peptides isolated in this fraction, such 274 
as caprine lactoferricin, which has been shown antibacterial activity against E. coli35. Ionic charge 275 
is crucial for the attachment of peptides to the bacterial membrane5; we had hypothesised that 276 
cationic peptides would have higher activity than anionic or non charged peptides however, our 277 
results did not agree with this.  The mechanism of action of milk-derived antimicrobial peptides 278 
remains uncertain and other physicochemical properties such as size amphiphilicity and 279 
conformation may play a role in their interaction with bacterial membranes.  280 
Experimental 281 
Samples 282 
Goat milk samples from the Murciano-Granadina local breed were obtained from local farms 283 
(Granada province, Southeastern Spain). Specifically, every week along five weeks five batches 284 
with five samples for StFM and for St+LPFM were done, according to a previously standardised 285 
procedure.32 Each individual sample was analysed by triplicate. 286 
 287 
Sample fractionation 288 
Fermented milk samples were fractioned in three steps (Fig. 4). In the first step the whey fraction 289 
was obtained. All samples were centrifuged at 3000g and 4 ºC for 30 min (Sigma 2-16PK, 290 
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Sartorius, Goettingen, Germany). Then, the supernatant was separated, freeze-dried and stored 291 
under refrigeration and nitrogen atmosphere until analysis. Before the fractionation, freeze-dried 292 
samples were dissolved in water up to the initial volume and then filtered through 0.22 μm size 293 
pore filters Millex® - GS (Merck Millipore Ltd., Cork, Ireland) in a laminar flow cabinet and 294 
stored in sterile containers. 295 
In the second step a cation exchange was applied. Sartobind filter MA-15 Units (Sartorius, 296 
Goettingen, Germany), with a strong acidic cation exchanger membrane. The procedure was 297 
carried out according to the operating instructions following four steps: (a) equilibration with 10 298 
mL of 10mM potassium phosphate buffer at pH 4.5; (b) loading with 5 mL of sample; (c) washing 299 
with 10 mL of equilibration buffer; (d) and finally elution with 5 mL of elution buffer 300 
(equilibration buffer + 1 M NaCl at pH 4.5). Then, the cation exchange units were cleaned with 301 
0.2 N NaOH for 30 min and equilibrated with 10 mL of equilibration buffer. All steps were 302 
conducted at 3 drops/s. With this method, two fractions for each sample were obtained: (1) 303 
Permeate (P) composed by anionic or zwitterions peptides and proteins at pH 4.5 that permeates 304 
when loading the sample; (2) and Retentate (R) composed by cationic peptides and proteins at pH 305 
4.5 retained in the resin and extracted in the elution step. We will refer to them as peptides because 306 
we assume that both fractions (P and R) could have bioactivity. 307 
In the third step ultrafiltration was applied; molecules will be separated according to size only 308 
by a membrane with molecular weight cut off (MWCO) of 3 KDa.  (Vivaspin20, Sartorius, 309 
Goettingen, Germany), The ion exchange permeates were fractionated into: (1) Permeate ( P<3 ) 310 
which contained compounds sized less than 3 kDa anionic or zwitterions peptides; (2) and retentate 311 
(P>3) which contained compounds sized more than 3 kDa anionic or zwitterions peptides and 312 
proteins. As stated above, we will refer to them as peptides. 313 
 314 
Total soluble protein content   315 
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The total protein content of the samples was determined based on the bicinchonic acid (BCA) 316 
assay according to the previously optimized method.36 The absorbance was measured at 562 nm 317 
within 10 min using an Ultrospec 1100 pro UV/Visible spectrophotometer (Amersham 318 
Biosciences, Little Chalfont, UK). Serial dilutions of bovine serum albumin (Sigma-Aldrich, 319 
Steinheim, Germany) were used as standard and bidistilled water as blank. 320 
 321 
Total antioxidant capacity (TAC) measured by ORAC, ABTS, DPPH and FRAP assays 322 
The TAC using the oxygen radical antioxidant capacity assay (ORAC) was determined according 323 
to the method described by Huang et al.37 slightly modified. In the ABTS assay, the antioxidant 324 
capacity was estimated in terms of radical scavenging activity following the procedure described 325 
by Pellegrini et al.38 In the DPPH assay, the antiradical activity of different samples was estimated 326 
according to the procedure reported by Brand-Williams et al.,39 which was adapted to a microplate 327 
reader. Finally for the FRAP determination the ferric reducing ability of each sample solution was 328 
estimated according to the procedure described by Benzie and Strain40 and also adapted to a 329 
microplate reader.  330 
 331 
 332 
 333 
 334 
 335 
Measurement of the ACEi% activity 336 
The ACE-inhibitory activity of the samples and fractions was measured following the HPLC-based 337 
method described by Gonzalez-Gonzales et al.,27 with some modifications. For this aim the 338 
determination was done by RP-UHPLC, using a Thermo Scientific Accela UHPLC system (Santa 339 
Clara, USA) with thermostated compartment sample injector at 10 ºC and a C18 analytical column 340 
(Extrasyl-ODS2, 250 x 4.0 mm, 5 mm, Tecknokroma, Barcelona, Spain) thermostated at 37 ºC. 341 
The injection volume was 10 µL and the photodiode array detector was set at 228 nm. The flow 342 
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rate was 1 mL/min with an isocratic solution of acetonitrile 12.5% and trifluoroacetic acid 0.1% 343 
in milli-Q water over 8 min, as it was previously reported.41   344 
 345 
Evaluation of the antimicrobial activity 346 
This activity was studied using two bacterial strains: a Gram-negative, Escherichia coli K-12 (E. 347 
coli), and a Gram-positive, Micrococcus luteus (M. luteus). Before the assay all samples were 348 
filtered through 0.22 μm size pore filters (Millex® - GS, Merck Millipore Ltd., Cork, Ireland) 349 
under laminar flow and stored in sterile containers. Every measurement was done in triplicate and 350 
sterile Phosphate Buffered Saline (PBS, Sigma-Aldrich, Steinheim, Germany) was assayed as 351 
blank. 352 
The antimicrobial activity of the whey, P and R fractions of StFM and St+LPFM was assayed 353 
by the well diffusion assay, based on the method described by Leon Ruiz et al.9 The antimicrobial 354 
activity was also evaluated by the spot assay of antibiosis, which was carried out according to the 355 
method described by Mohankumar and Murugalatha42 slightly modified. The agar was inoculated 356 
with the bacteria prepared as described above. Instead of doing wells, three 20 μL drops of each 357 
sample were put on the agar and the plates were incubated as described above. Inhibition zones 358 
were measured from the edge of the drop. 359 
Finally, for the determination of the antimicrobial activity by the co-culture assay, 4.5 mL of 360 
broth culture (NB for E. coli and TSB for M. luteus), 0.5 mL of the sample and 50 μL of the 361 
bacteria suspension (growth in NB or TSB at ~ 6-8x108cfu mL-1), were cultured all together. This 362 
mixture was incubated under stirring at 37 ºC for E. coli and 30 ºC for M. luteus. Aliquots at t= 0, 363 
2, 4, 8 and 24 h were taken, plated out and incubated 24h at 37ºC in NA for E.coli and 48-72 h at 364 
30 ºC in TSA for M. luteus. Finally, the colonies were counted and the mean for each plate was 365 
calculated and expressed as cfu mL-1. 366 
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 367 
Statistical analysis 368 
The homogeneity of variances was first assessed using the Levene’s test at a significance level of 369 
5% (p < 0.05). The data normal distribution was assayed with the Shapiro-Wilk test at a 370 
significance level of 5% (p < 0.05). Statistical analysis of data corresponding to different fractions 371 
of the same milk type was  tested using the ANOVA test when the parametric conditions were 372 
fulfilled or using the Kruskall-Wallis test for non-parametric ones.  Additionally, to check the 373 
existence of statistical differences between same fractions (and whey samples) from different 374 
fermented milks (with and without the probiotic) the pair wise independent t-test was used. The 375 
evaluation of the relationship between different assays was carried out by computing the relevant 376 
correlation coefficient at the p < 0.05 confidence level by Pearson linear correlation (for normal 377 
distribution of data) or Spearman linear correlation (for non-normal distribution of data). Analyses 378 
were performed using SPSS 17.0 program (Windows version; SPSS Inc., Chicago, IL). The 379 
significance value p < 0.05 showed the existence of significant differences. 380 
 381 
Conclusions  382 
A remarkable TAC and high ACEi activity for both fermented goat milks (StFM and St+LPFM) 383 
were found. The whey was in general one of the most active fractions in all the assays. 384 
However the fractionation of the whey according to size and charge gave a very good insight into 385 
the relationship between these physicochemical properties (hence chemical structure) and activity 386 
measured as antioxidant, antimicrobial and ACEi activity. Interestingly the highest TAC measured 387 
by ORAC was found in the P<3 fraction, therefore peptides with MW<3000 Da were the main 388 
contributors to the antioxidant activity not the proteins. On the other hand, positively charged basic 389 
peptides (those in the retentate fraction of the membrane separation step) had the highest TAC 390 
against ABTS•+ and DPPH• radicals; both methods test antioxidant mechanism according to HAT 391 
17 
 
and SET mechanisms. In terms of ACEi activity, the highest activity was found in the P<3 fraction. 392 
So the smallest (nonionic and anionic) peptides were the main contributors to the ACEi and 393 
antioxidant (according to ORAC) activities of the whey. 394 
None of the samples had antimicrobial activity against the gram positive bacteria. The whey and 395 
the anionic/nonionic fractions of the fermented milk with the starter had some antimicrobial 396 
activity against the gram negative bacteria however, this may be partly due to the low pH.  Only 397 
the whey and the cationic fraction of the fermented milk with the probiotic showed some activity 398 
against E.coli which could be attributed to peptides released by L. plantarum C4 during the 399 
fermentation process such as those derived from lactoferrin. 400 
Finally, the activities attributed to the whey fractions show potential health benefits of the 401 
consumption of fermented goat milk. However, further research is needed to conduct clinical trials 402 
to substantiate these and for further identification of individual peptides responsible for the 403 
activities. 404 
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 469 
  470 Table 1. Total protein content in the different fractions of goat fermented 
milks (mean ± SD, mg mL-1) 
Sample 
type 
n Whey fraction  P fraction R fraction  
P<3 KDa 
fraction 
P>3 KDa 
fraction 
StFM 25 6.78±0.773* 5.69±0.548# 0.436±0.096 2.23±0.145 1.31±0.377 
St+LPFM 25 5.70±0.661* 4.30±0.843# 0.355±0.055 2.08±0.127 0.97±0.142 
Mean 
value 
50 6.16±0.868a,* 4.85±0.990b,# 0.388±0.076c,** 2.14±0.143d,## 1.19±0.225e, 
StFM: Fermented milk manufactured with skimmed milk concentrated by ultrafiltration (UFM) and fermented with the 
classical starter bacteria (St: L. bulgaricus and S. thermophilus); St+LPFM: Probiotic fermented goat milk manufactured with 
UFM and fermented with St and L. plantarum C4; Whey fraction: Fermented milk supernatant after centrifugation; P fraction: 
IEX (Ion exchange) permeate; R fraction: IEX retentate; P<3 fraction: P fraction with less than 3 kDa molecular weight; P>3 
kDa fraction: P fraction with more than 3 kDa molecular weight.  
*,#Statistical differences between the same fractions of StFM and St+LPFM: p < 0.05.  
a,b,c,d,e,Superscripts with different letters indicate the existence of statistical differences among different fractions:  *p < 0.01; 
**,##,p < 0.001). 
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Table 2. Final pH of the co-culture supernatants at 24h for fermented goat milks (StFM 
and St+LPFM) and control 
Sample n Whey fraction P fraction R fraction  Control 
StFM (TSB) 25 5.04 ± 0.07 5.06 ± 0.01 7.46 ± 0.07 7.30 ± 0.18 
St+LPFM (NB) 25 4.91 ± 0.07 4.83 ± 0.01 6.64 ± 0.01 6.85 ± 0.12 
The pH was measured in the supernatant of the culture media mixed with the fractions after the assay. TSB: Tryptone soy broth culture media; 
NB: Nutrition broth culture media; WHEY: Fermented milk supernatant after centrifugation; P: IEX (Ion exchange) permeate; R: IEX retentate; 
Control: Sterile PBS. 
 471 
  472 
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Fig. 1. Antioxidant activity (TEAC mL-1 and TEAC mg protein-1) of the fermented milk fractions 
by ORAC, ABTS, DPPH and FRAP assays 
StFM: Fermented goat milk manufactured with skimmed goat milk concentrated by ultrafiltration (UFM) and fermented with the classical 
starter bacteria (St) L. bulgaricus and S. thermophilus; St+LPFM: Probiotic fermented goat milk manufactured with UFM and fermented 
St and L. plantarum C4; Whey fraction: Fermented milk supernatant after centrifugation; P fraction: IEX (Ion exchange) permeate; R 
fraction: IEX retentate; P<3 fraction: P fraction with less than 3 kDa molecular weight; P>3 fraction: P fraction with more than 3 kDa 
molecular weight.  
*,#,,**,##,,,***,###,Statistical differences between values for StFM and St+LPFM: *,#,p < 0.05; **,##,,p< 0.01; ***,###,p< 0.001 
a,b,c,d,eSuperscripts with different letters indicate the existence of significant differences among fractions (letter : p < 0.05; letter,*,#,: p < 0.01; 
letter, **,##,,: p < 0.001). 
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 478 
 479 
Fig. 2. Angiogensin-I-converting-enzyme inhibitory activity (ACEi) of StFM and St+LPFM 480 
expressed as percentage of ACE inhibition (a) and inhibitory efficiency ratio (IER; b). 481 
StFM: Fermented goat milk manufactured with skimmed goat milk concentrated by ultrafiltration (UFM) and fermented with the 482 
classical starter bacteria (St) L. bulgaricus and S. thermophilus; St+LPFM: Probiotic fermented goat milk manufactured with 483 
UFM and fermented St and L. plantarum C4; Whey fraction: Fermented milk supernatant after centrifugation; P fraction: IEX 484 
(Ion exchange) permeate; R fraction: IEX retentate; P<3 fraction: P fraction with less than 3 kDa molecular weight; P>3 fraction: 485 
P fraction with more than 3 kDa molecular weight.  486 
*,#,,**,##Statistical differences between values for StFM and St+LPFM: *,#,p < 0.05; **,##p< 0.01 487 
a,b,c,d,eSuperscripts with different letters indicate the existence of significant differences among fractions (letter : p < 0.05; letter, *,#,: 488 
p < 0.01; letter,**,##: p < 0.001). 489 
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 494 
Fig. 3. Antimicrobial activity measured as viable E. coli after co-culture with the different 495 
fractions from StFM (a) and St+LPFM (b) 496 
StFM: Fermented goat milk manufactured with skimmed goat milk concentrated by ultrafiltration (UFM) and fermented with the 497 
classical starter bacteria (St) L. bulgaricus and S. thermophilus; St+LPFM: Probiotic fermented goat milk manufactured with UFM 498 
and fermented St and L. plantarum C4; Whey fraction: Fermented milk supernatant after centrifugation; P fraction: IEX (Ion 499 
exchange) permeate; R fraction: IEX retentate; P<3 fraction: P fraction with less than 3 kDa molecular weight; P>3 fraction: P 500 
fraction with more than 3 kDa molecular weight; Control: sterile PBS.  501 
*,***,###Significant differences for viable E. coli at specific time among fractions of fermented goat milks and the control: *p < 502 
0.05; ***,###p< 0.001. 503 
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Fig. 4. Sample fractionation diagram for skimmed goat milks with classical starter bacteria 537 
(StFM) and with the classical starter St plus Lactobacillus plantarum C4 probiotic strain 538 
(St+LPFM) 539 
Whey: Fermented milk supernatant after centrifugation; Cationic fraction: Ion exchange (IEX) permeate; Anionic fraction: IEX retentate; P<3 540 
fraction: P fraction with less than 3kDa molecular weight; P>3 fraction: P fraction with more than 3kDa molecular weight. 541 
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